Hamlet BioPharma AB publ (XSAT:HAMLET B) Buyback Yield %: -3.08 (As of Aug. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:HAMLET B Hamlet BioPharma AB publ XSAT:HAMLET B
31 GF Score
Price kr6.67
! 2 Warning Signs
View Full Analysis

What is Hamlet BioPharma AB publ Buyback Yield %?

Hamlet BioPharma AB publ XSAT:HAMLET B -1.91% 31 Buyback Yield % is -3.08 as of Aug. 18, 2026. GuruFocus rates XSAT:HAMLET B with a GF Score™ of 31/100. The stock has 2 warning signs investors should review. Among 724 Biotechnology companies, Hamlet BioPharma AB publ ranks better than 67.27% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Hamlet BioPharma AB publ's current buyback yield was -3.08%.

Hamlet BioPharma AB publ Buyback Yield % Related Terms

Hamlet BioPharma AB publ Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Hamlet BioPharma AB publ's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hamlet BioPharma AB publ Buyback Yield % Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -13.02 -1.12 -6.73 -3.66

Hamlet BioPharma AB publ Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.80 -3.66 -5.51 -2.75 -2.58

XSAT:HAMLET B vs VRTX, REGN, RVMD: Buyback Yield % Comparison

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hamlet BioPharma AB publ Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Buyback Yield % falls into.


XSAT:HAMLET B
31GF Score
Hamlet BioPharma AB publ XSAT:HAMLET B
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hamlet BioPharma AB publ Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Hamlet BioPharma AB publ's Buyback Yield for the fiscal year that ended in Jun. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 26.79) / 732.950625
=-3.66%

Hamlet BioPharma AB publ's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 39.113) / 1514.2284
=-2.58%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -3.08 mean?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a Buyback Yield % of -3.08 as of Aug. 18, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hamlet BioPharma AB publ and its competitors. According to the industry distribution chart, Hamlet BioPharma AB publ ranks #237 out of 724 companies in the Biotechnology industry, placing it in the top 32.7%.
Is Hamlet BioPharma AB publ's Buyback Yield % too high?
Hamlet BioPharma AB publ's current Buyback Yield % is -3.08. Based on the distribution chart, Hamlet BioPharma AB publ ranks #237 out of 724 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Hamlet BioPharma AB publ has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Hamlet BioPharma AB publ's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Hamlet BioPharma AB publ ranks #237 out of 724 companies for Buyback Yield %. This puts Hamlet BioPharma AB publ in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hamlet BioPharma AB publ and its competitors. Hamlet BioPharma AB publ's current Buyback Yield % is -3.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hamlet BioPharma AB publ stock overvalued right now?
Hamlet BioPharma AB publ (XSAT:HAMLET B) has a current Buyback Yield % of -3.08. The current Buyback Yield % is -3.08. Hamlet BioPharma AB publ's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Hamlet BioPharma AB publ (XSAT:HAMLET B), the current Buyback Yield % is -3.08 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hamlet BioPharma AB publ Business Description

Other Exchanges 7ZT:Germany
Address Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.
31GF Score

Get the complete analysis for XSAT:HAMLET B

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr6.67
Price